Splenectomy for optimal cytoreduction in ovarian cancer

Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001

Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas.

American journal of clinical pathology·2001

Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: a Gynecologic Oncology Group Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1999

Cell proliferation-associated proteins in endometrial carcinomas, including papillary serous and endometrioid subtypes.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists·1998

Amonafide in patients with leiomyosarcoma of the uterus: a phase II Gynecologic Oncology Group study.

American journal of clinical oncology·1998

Molecular characterization of NSMP endometrial cancer and its relevance for treatment.

Gynecologic oncology·2026

High rates of venous thromboembolism in endometrial cancer patients requiring systemic therapy: an opportunity for risk assessment and intervention.

Gynecologic oncology·2026

Leveraging artificial intelligence in the early detection of ovarian cancer: Development and validation of a risk prediction model.

Gynecologic oncology·2026

The science and conduct of surgical trials in gynecologic oncology: A practical framework.

Gynecologic oncology·2026

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Gynecologic oncology·2026

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Gynecologic oncology·2026

Combined inulin, glucomannan, and medium-chain triglyceride modulate metabolic and inflammatory responses in chemotherapy-treated colorectal cancer cells.

Journal of advanced pharmaceutical technology & research·2026

Erratum: Evaluation of the combination of chitosan hydrogel crosslinker and dental pulp stem cell-derived exosomes on osteoblast viability and differentiation.

Journal of advanced pharmaceutical technology & research·2026

Engineered Nanozymes for Colorectal Cancer Therapy: Catalytic Reprogramming of the Tumor Microenvironment.

International journal of nanomedicine·2026

Selenium-Doped Calcium Hydroxide Nanoparticles Inhibit Osteoclasts and Promote Osteogenesis for Osteoporosis Treatment.

International journal of nanomedicine·2026

Efficacy of cryotherapy for oral leukoplakia: A systematic review.

Journal of dental sciences·2026

The multifaceted impact of the COVID-19 pandemic on colorectal cancer care: a systematic review of management disruptions, stage migration, and survival outcomes.

Frontiers in oncology·2026

Related Experiment Videos

Splenectomy for optimal cytoreduction in ovarian cancer

Related Concept Videos

Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancer.

Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas.

Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: a Gynecologic Oncology Group Study.

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.

Cell proliferation-associated proteins in endometrial carcinomas, including papillary serous and endometrioid subtypes.

Amonafide in patients with leiomyosarcoma of the uterus: a phase II Gynecologic Oncology Group study.

Molecular characterization of NSMP endometrial cancer and its relevance for treatment.

High rates of venous thromboembolism in endometrial cancer patients requiring systemic therapy: an opportunity for risk assessment and intervention.

Leveraging artificial intelligence in the early detection of ovarian cancer: Development and validation of a risk prediction model.

The science and conduct of surgical trials in gynecologic oncology: A practical framework.

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Combined inulin, glucomannan, and medium-chain triglyceride modulate metabolic and inflammatory responses in chemotherapy-treated colorectal cancer cells.

Erratum: Evaluation of the combination of chitosan hydrogel crosslinker and dental pulp stem cell-derived exosomes on osteoblast viability and differentiation.

Engineered Nanozymes for Colorectal Cancer Therapy: Catalytic Reprogramming of the Tumor Microenvironment.

Selenium-Doped Calcium Hydroxide Nanoparticles Inhibit Osteoclasts and Promote Osteogenesis for Osteoporosis Treatment.

Efficacy of cryotherapy for oral leukoplakia: A systematic review.

The multifaceted impact of the COVID-19 pandemic on colorectal cancer care: a systematic review of management disruptions, stage migration, and survival outcomes.

Related Experiment Videos

Splenectomy for optimal cytoreduction in ovarian cancer

Abstract:

Related Concept Videos

Related Articles